In a regulatory filing, Cingulate (CING) disclosed that on August 7, the employment of Laurie Myers, Executive Vice President and Chief Operating Officer, terminated.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CING:
- Cingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating
- Cingulate Inc Submits NDA for ADHD Treatment
- Cingulate submits CTx-1301 NDA to FDA
- Cingulate Inc. Receives Buy Rating: PDUFA Fee Waiver and Competitive Edge of CTx-1301 Boost Market Prospects
- Cingulate receives $4.3M waiver from FDA for NDA for CTx-1301